|

The Top 10 Psychedelics Stocks’ Financials COMPARED ( Atai, CMPS, MNMD, NUMI, RVV, DMT, TRIP+)

ByPsychedelic Spotlight

What’s up psychedelic investors! In this episode, we’ll be comparing the top 10 psychedelic stocks’ financials.
Will look at the 4 most important financial stats for each of the top 10 companies in the Psychedelic Medicines field, selected by market cap.

First, we will look at the market cap, because that tells us how valuable the market judges the company to be, and it tells us how easily a company can raise capital.
Next, we will look at cash on hand.
Third, we will look at how much a company is spending.
Finally, we will look at revenue where applicable
All figures are in American dollars.

So which stocks we’ll be comparing, you may ask? We’ll look at:
– Atai Life Sciences ( NASDAQ: ATAI)
– Compass Pathways (NASDAQ: CMPS)
-MindMed (NASDAQ: MNMD), ( NEO: MMED)
– Cybin Inc (NYSE: CYBN)
– Numinus Wellneass (TSX: NUMI) (OTC: LKYSF)
– Revive Therapeutics (CN: RVV) (OTC: RVVTF)
– Small Pharma ( TSX: DMT)
-Mydecine (OTC: MYCOF) (NEO: MYCO)
– Red Light Holland ( CSE: TRIP) (OTC: TRUFF)

Enjoy the episode!

Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor

Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com

Music from:
www.bensound.com

Video editing: @themyaholy

Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor

DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

#MindMed #ATAISTOCK #PsychedelicStocks

Similar Posts

  • The Mainstream Media GETS Psychedelic Stocks [Like MMEDF, CMPS, EHVVF & FTRPF]

    Listen, Videos

    Hello psychedelic investors! Today’s episode will be a little different. We will discuss the recent media coverage of psychedelic stocks and its role in psychedelic inspired companies’ future.
    It appears that the mainstream media understands the potential for psychedelic stocks to disrupt the pharmaceutical Industry. Now understanding what this means, and its implications is extremely important for retail investors like you and me.
    We’ll also zoom into one piece of media about MindMed (MMED/MMEDF) and Compass Pathways (CMPS), and explore how it hits the nail on the head.
    We are going to do this because one, it’s a good article that I wanted to share with you
    And two, it exemplifies my point that the mainstream understands the potential here, and might actually be on the right side of history.

    P.S. I mention in the video that the article I’m discussing is by Yahoo Finance. It turns out the article is from OTC stock review.
    For those interested in reading the entire article: https://ca.movies.yahoo.com/264-million-reasons-psychedelic-stocks-133000885.html

    Time Stamps
    0:00​ – Intro
    3:10 – Media Coverage on Tesla & Psychedelic Stocks
    6:36 – Benefits of the media covering Psychedelic Companies like (MMEDF & CMPS)
    8:05 – Influence on stock valuations and stealth investors
    10:57 – 264 Million Reasons Why Psychedelic Stocks Have More Room To Grow

    I hope you guys found some value in this and I’ll keep you posted for more changes!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor

    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #MindMed​​ ​ #MindmedStock​​ #PsychedelicStocks

  • New Players, BUY Ratings, Financial Results & MORE ( MINDMED, NUMI, CMPS, MYCO, FTRP, HAVN, DMT)

    Listen, Videos

    There were A LOT OF DEVELOPMENTS THIS WEEK, so strap on your seat belts and let’s dive into what happened this week with: MindMed ( MMED / MNMD / MMQ ), Compass Pathways (CMPS), NUMINUS (NUMI), Fieldtrip Health (FTRP / FTRPF), Mydecine ( MYCO / MYCOF), HAVN Labs
    ( HAVN / HAVLF), Novamind ( NM / NVMDF), Champignon Brands aka Braxia Scientific
    (old ticker :SHRM / new ticker: BRAX / BRAXF), Nova Mentis (NOVA / NMLSF) and Small Pharma (DMT).

    Timestamps:
    0:00 – Intro
    0:54 – MindMed’s (MMED / MNMD) Project Angie Announcement
    1:47 – Compass Pathways (CMPS) Q1 Financial Results Date & Business Updates
    3:16 – Analyst Coverage and Buy Ratings for CMPS
    4:35 – Mydecine ( MYCO / MYCOF) 2020 Financial Results & Business Highlights
    9:17 – Numinus Wellness (NUMI) Q2 Financial Results
    11:25 – Field Trip Health (FTRP/ FTRPF) Opens more clinics
    12:19 – Novamind ( NM / NVMDF) doubling its clinics
    14:25 – Champignon Brands (SHRM /SHRMF) changing its named to Braxia Scientific (BRAX / BRAXF)
    15:31 – NEW DMT company that began trading on may 6th under the name SMALL PHARMA ( DMT)
    17:19 – HAVN Labs (HAVN) opens a new lab in Jamaica
    17:50 – Nova Mentis launches a new clinical study using psilocybin to treat autism

    Link to MindMed’s Project Angie Press release:
    https://mindmed.co/news/press-release/mindmed-announces-project-angie-targeting-the-treatment-of-pain-with-psychedelics/

    Link to Compass Pathways Q1 financial Results date:
    https://ir.compasspathways.com/news-releases/news-release-details/compass-pathways-plc-announce-first-quarter-2021-financial

    Link to Compass Pathways (CMPS) analyst ratings: https://www.marketbeat.com/stocks/NASDAQ/CMPS/price-target/

    Link to Mydecine ( MYCO/ MYCOF) Full Year 2020 Financial results Plus business updates
    https://www.globenewswire.com/news-release/2021/05/03/2221266/0/en/Mydecine-Reports-Full-Year-2020-Financial-Results-and-Provides-Business-Update.html

    Link to Numinus (NUMI) Q2 2021 Financial Results:
    https://www.newswire.ca/news-releases/numinus-wellness-q2-2021-results-highlighted-by-17-25-million-financing-mindspace-wellbeing-acquisition-and-clinical-trial-collaboration-with-maps-pbc-846735411.html

    Link to Field Trip’s (FTPR / FTPRF) 7th Psychedelic-assisted therapy Clinic:
    https://psilocybinalpha.com/news/field-trip-health-ltd-announces-opening-of-psychedelic-enhanced-therapy-center-in-houston-locations-of-next-5-field-trip-health-centers

    Link to Novamind’s (NM / NVMDF) Ketamine Clinic article:
    https://novamind.ca/2021-05-04-novamind-doubles-in-size-adds-four-new-psychedelic-mental-health-clinics/

    Link to Champignon Brands ( SHRM/ SHRMF) announcing their name change to Braxia Scientific (BRAX / BRAXF):
    https://thedeepdive.ca/champignon-brands-to-change-name-to-braxia-scientific/

    Link to Small Pharma ( DMT):
    https://psilocybinalpha.com/news/small-pharma-completes-reverse-take-over-transaction

    Link to Havn’s (HAVN / HAVLF) Jamaica lab:
    https://www.psychedelicfinance.com/articles/havn-labs-jamaica-facility-now-fully-operational

    Link to Nova Mentis launching a clinical study to learn more about Autism:
    https://psilocybinalpha.com/news/nova-mentis-launches-autism-clinical-study

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌

    Instagram: @psychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    editing by: @themyaholy
    Music: www.bensound.com
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #Numi #CMPS